Eterna Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eterna Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Eterna Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $719K, a 97.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $719K -$34.1M -97.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $36M +$633K +1.79% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $36.5M +$35.5M +3593% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $32.8M +$31.8M +3083% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $34.9M +$32.9M +1723% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $35.4M +$35.4M Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $989K -$411K -29.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.03M -$1.54M -59.9% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.91M -$754K -28.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 -$2.77M -100% Jun 30, 2022 10-K 2023-03-20
Q1 2022 $1.4M -$623K -30.8% Mar 31, 2022 10-K 2024-03-14
Q4 2021 $2.57M +$474K +22.6% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $2.67M +$2.66M +53217% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.77M +$2.72M +6190% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $2.02M +$21.3K +1.06% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.09M -$8K -0.38% Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 $5K -$2.17M -99.8% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $44K -$2.2M -98% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2M -$262K -11.6% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 $2.1M -$199K -8.65% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $2.18M Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $2.25M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $2.26M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $2.3M Dec 31, 2018 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.